Table of Contents
Which doctor is best for hepatitis B?
Doctors who specialize in treating hepatitis B include:
- Doctors who treat digestive diseases (gastroenterologists)
- Doctors who treat liver diseases (hepatologists)
- Doctors who treat infectious diseases.
How much does hepatitis B treatment cost?
The price for a full course of treatment can range from $55,000 to $150,000. As a result, government insurance programs such as Medicaid and Medicare have limited their use to patients with late-stage disease, and private insurers have imposed onerous copayments, paperwork and delays on patients and their doctors.
Is hepatitis B 100\% curable?
There’s no cure for hepatitis B. The good news is it usually goes away by itself in 4 to 8 weeks. More than 9 out of 10 adults who get hepatitis B totally recover. However, about 1 in 20 people who get hepatitis B as adults become “carriers,” which means they have a chronic (long-lasting) hepatitis B infection.
Which hospital is best for hepatitis B treatment in India?
The RIMC Advantage RIMC is one of the best hospitals for hepatitis b treatment in Chennai, India. Liver specialists, expert dieticians and world class medical care are available under one roof at RIMC.
Is hepatitis B common in India?
In India, the prevalence of hepatitis B surface antigen (HBsAg) is 3–4.2\% with over 40 million HBV carriers. Every year over 115000 Indians die of hepatitis B related complications.
Who is the best doctor of hepatitis B in India?
Best Hepatitis B Treatment Doctors in India
- Dr. Sujit Chaudhury. Medical Gastroenterologist, Kolkata, India.
- Dr. Pawan Rawal. Medical Gastroenterologist, Gurgaon, India.
- Dr. Apurba K Pal. Medical Gastroenterologist, Kolkata, India.
- Dr. Mahesh Goenka.
- Dr. Satish G Kulkarni.
- Dr. Gaurav Mehta.
- Dr. Naveen Polavarapu.
- Dr. Mohan A .
What tea is good for hepatitis B?
Conclusion. Green tea consumption may protect against development of primary HCC. Potential effect modifications of green tea on associations between primary HCC and alcohol drinking, HBV/HCV infection, and inflammation-related SNPs were suggested.